Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:00:20 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Q:PRQR - PROQR THERAPEUTICS N V - https://www.proqr.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PRQR - Q0.11.47·2.470.42.26-0.14-5.8280.55692,0342.42  2.47  2.254.6199  1.07518:55:30Jun 2615 min RT 2¢

Recent Trades - Last 10 of 2034
Time ETExPriceChangeVolume
18:55:30Q2.26-0.147
18:45:25Q2.26-0.141
16:04:03Q2.26-0.141
16:04:02Q2.26-0.141
16:00:00Q2.26-0.14154
16:00:00Q2.26-0.14145
16:00:00Q2.26-0.141
16:00:00Q2.26-0.1433
16:00:00Q2.26-0.1466
16:00:00Q2.26-0.1426

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-26 16:30U:PRQRNews ReleaseProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
2025-05-12 08:00U:PRQRNews ReleaseProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
2025-05-08 07:00U:PRQRNews ReleaseProQR Announces First Quarter 2025 Operating and Financial Results
2025-05-02 08:00U:PRQRNews ReleaseProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
2025-05-01 08:00U:PRQRNews ReleaseProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
2025-04-14 07:00U:PRQRNews ReleaseProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
2025-03-13 07:00U:PRQRNews ReleaseProQR Announces Year End 2024 Operating and Financial Results
2024-12-11 07:00U:PRQRNews ReleaseProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
2024-12-10 08:00U:PRQRNews ReleaseProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
2024-12-05 08:00U:PRQRNews ReleaseProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024
2024-11-07 07:00U:PRQRNews ReleaseProQR Announces Third Quarter 2024 Operating and Financial Results
2024-10-25 16:45U:PRQRNews ReleaseProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
2024-10-22 22:15U:PRQRNews ReleaseProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
2024-10-22 16:01U:PRQRNews ReleaseProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
2024-10-07 08:00U:PRQRNews ReleaseProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
2024-09-10 16:30U:PRQRNews ReleaseProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
2024-08-08 07:00U:PRQRNews ReleaseProQR Announces Second Quarter 2024 Operating and Financial Results